Repurposing anti-osteoporosis drugs for autoimmune diseases: A two-sample Mendelian randomization study

Repurposing anti-osteoporosis drugs for autoimmune diseases: A two-sample Mendelian randomization study

Background: Despite the increasing availability of therapeutic drugs for autoimmune diseases, many patients still struggle to achieve their treatment goals. Our aim was to identify whether drugs originally used to treat bone density could be applied to the treatment of autoimmune diseases through Me...

Full description

Bibliographic Details
Main Authors: Pan Xiang, Chengyuan Yang, Ruoyi Shen, Xiaoxiong Huang, Xuerong Huang, Qi Cheng, Zongping Luo, Qin Zhang
Format: Article
Language:English
Published: Elsevier 2024-07-01
Series:Heliyon
Subjects:
Bone mineral density
Autoimmune diseases
Drug re-purposing
Mendelian randomization
ESR1
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024105257

Internet

http://www.sciencedirect.com/science/article/pii/S2405844024105257

Similar Items